Alpelisib-Induced Diabetic Ketoacidosis in a Patient With Metastatic Breast Cancer

We report the case of a 45-year-old woman with metastatic breast cancer who started treatment with alpelisib nine days before developing diabetic ketoacidosis (DKA). At the time of DKA diagnosis, blood tests showed a capillary blood glucose of 30 mmol/L, serum carbon dioxide level of 11 mmol/L, an a...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Zeyoudi, Jawaher, El Kebbi, Imad, Al Zaabi, Fatima, Hashmi, Shahrukh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799918/
https://www.ncbi.nlm.nih.gov/pubmed/35141074
http://dx.doi.org/10.7759/cureus.20817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799918/
https://www.ncbi.nlm.nih.gov/pubmed/35141074
http://dx.doi.org/10.7759/cureus.20817

Ejemplares similares